Risk Factors Update Summary
- Any product candidates will compete with new therapies from pharmaceutical markets, impacting commercial opportunity.
- Competitors developing additional products may reduce our commercial opportunity and success.
- Delays in patient enrollment may impact clinical trials, timelines, and regulatory approvals.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1622229&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.